The Sales & Marketing Effectiveness in Chemicals Forum will bring together industry leaders as well as experts responsible and deeply involved in sales and marketing strategies.
January 2016 to start new era for pharma companies in Europe
The past decade has witnessed a wave of global transparency in the pharmaceutical industry, and 2015 has marked the start of a new era in Europe. From January 2016, pharma companies will make their transfers of value public to healthcare professionals and healthcare organisations in Europe.
Therefore, Fleming Europe has decided to gather the experts at its 4th edition of Corporate Compliance and Transparency in the Pharmaceutical Industry and make sure that these companies have entered the new year prepared.
On the 24th of February 2016, legal and compliance professionals from Johnson & Johnson, Novo Nordisk, Sandoz, Mylan, Actavis, Boehringer-Ingelheim, GlaxoSmithKline and many more will meet in Zurich to prepare for not only a huge technical challenge but also a major cultural shift.
During the two focused days, attendees will get an update on the Disclosure Code implementation and its first outcomes and learn how to optimise interactions with HCPs and HCOs through a fully compliant and transparent strategy.
Richard Bergstrom, Director General at EFPIA, will open the first conference day with an on-stage interview. Representatives from Novo Nordisk will present their local perspective and lessons learned. The Director General of the European Generic and Biosimilar Medicines Association will outline the Code of Conduct for the European Generic and Biosimilar Medicines Industry.
The second conference day will focus on risk assessment, communication with third parties along with their training and monitoring, internal investigations and the best practices in compliance programme structure and their effectiveness.
If you don't want your ideas to sit and gather dust, join Fleming Europe's 4th edition of Corporate Compliance and Transparency in the Pharmaceutical Industry. You are also welcome to join the discussions in the Pharma SFE & Marketing Forum
Interested in this topic?
Process Scale-Up in Pharma (Solid Dosage Forms)
The major objective of this course is to provide a detailed insight into the practical aspects and approaches of process scale-up for different unit operations and technologies.
Patient Adherence and Engagement
Discuss the issues of non-adherence with other stakeholders and find a solution together with the patients themselves.
Next Generation Antibody Therapeutics
This focused 2-day training will cover the discovery, engineering and production of next-generation antibodies, antibody fragments, bispecific Abs, innovative ADCs and more. Follow the path from their discovery and selection through engineering and expression to production and regulatory issues.
Turning Patient Feedback to Meaningful Resource for Care Delivery
Read the interview with Nasser Al Naimi, Deputy Chief Quality Officer at Hamad Medical Corporation, and Co-Director at Hamad Healthcare Quality Institute, and learn how to turn your data into strategic information to drive patient-family centered care.
Creating & Leading Patient Experience Excellence
Read the full interview with Dr. Ahmed Mohammad Abu-Abah, CEO at King Abdullah BinAbdulaziz University Hospital and gain insight into the creating & leading patient experience excellence.
Excelling in PV is not only about Technical Expertise
For a PV leader, to be successful can look like a daily Herculean work: meeting a crucial mandate to minimize harm to patients, while ensuring that a product is prescribed to the right population, and maintaining the highest level of compliance within a very complex set of worldwide regulations.